A Primer of Drug Action. Dieser Artikel ist nicht verfügbar.A Primer of Drug Action

About the Author(s)

Robert M. Julien, M.D., received his M.S. and Ph.D. in Pharmacology from the University of Washington and his Medical Degree from the University of California at Irvine. His many research articles focus on the psychopharmacology of sedative and antiepileptic drugs. Previously an Associate Professor of Pharmacology and Anesthesiology at the Oregon Health Sciences University, he currently practices anesthesiology in Portland, Oregon.

Claire D. Advokat, professor of psychology at LSU, received her Ph.D. from Rutgers University. Her primary interest is in understanding the clinical effectiveness and the mechanism of action of drugs used in the treatment of mental illness, such as the antipsychotics, antidepressants, mood stabilizers, and anxiolytics.

Joseph Comaty, Adjunct Professor at LSU, received his Ph.D. in clinical psychology from Rosalind Franklin University of Science and Medicine. His primary area of research is clinical psychopharmacology. In particular, he is interested in the study of the clinical treatment for the major psychiatric disorders of schizophrenia, major depression, and bipolar disorder.

About the Author(s)

Robert M. Julien, M.D., received his M.S. and Ph.D. in Pharmacology from the University of Washington and his Medical Degree from the University of California at Irvine.  His many research articles focus on the psychopharmacology of sedative and antiepileptic drugs.  Previously an Associate Professor of Pharmacology and Anesthesiology at the Oregon Health Sciences University, he currently practices anesthesiology in Portland, Oregon.
 
Claire D. Advokat, professor of psychology at LSU, received her Ph.D. from Rutgers University.  Her primary interest is in understanding the clinical effectiveness and the mechanism of action of drugs used in the treatment of mental illness, such as the antipsychotics, antidepressants, mood stabilizers, and anxiolytics.
 
Joseph Comaty, Adjunct Professor at LSU, received his Ph.D. in clinical psychology from Rosalind Franklin University of Science and Medicine.  His primary area of research is clinical psychopharmacology.  In particular, he is interested in the study of the clinical treatment for the major psychiatric disorders of schizophrenia, major depression, and bipolar disorder.